BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32811351)

  • 21. Surgical treatment of young women with breast cancer: Public vs private hospitals.
    Patel A; Wang WJ; Warnack E; Joseph KA; Schnabel F; Axelrod D; Dhage S
    Breast J; 2019 Jul; 25(4):625-630. PubMed ID: 31074047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.
    Haffty BG; McCall LM; Ballman KV; Buchholz TA; Hunt KK; Boughey JC
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):174-182. PubMed ID: 31085287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or younger.
    Lammers EJ; Huibers P; van der Sangen MJ; van de Poll-Franse LV; Poortmans PM; Ernst MF; Lemaire BM; Meijs CM; Nuytinck HK; Voogd AC
    Breast; 2010 Feb; 19(1):44-9. PubMed ID: 19913419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of patients with pemphigus treated by the same physicians in a public safety net healthcare system vs. a private healthcare system.
    Kasperkiewicz M; Lai O; Recke A; Betlachin A; Ji L; Groshen S; Woodley D
    Br J Dermatol; 2019 Oct; 181(4):850-852. PubMed ID: 30959576
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Operation with less adjuvant therapy for elderly breast cancer.
    Yamada A; Narui K; Sugae S; Shimizu D; Takabe K; Ichikawa Y; Ishikawa T; Endo I
    J Surg Res; 2016 Aug; 204(2):410-417. PubMed ID: 27565077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
    Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
    Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?
    Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.
    Kumachev A; Trudeau ME; Chan KK
    Cancer; 2016 Mar; 122(6):893-8. PubMed ID: 26696022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
    Parikh RR; Housman D; Yang Q; Toppmeyer D; Wilson LD; Haffty BG
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1056-63. PubMed ID: 18676094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women.
    Kaplan HG; Malmgren JA; Atwood MK
    J Geriatr Oncol; 2013 Apr; 4(2):148-56. PubMed ID: 24071540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis in women with breast cancer and private extra insurance coverage.
    Grau JJ; Zanon G; Caso C; Gonzalez X; Rodriguez A; Caballero M; Biete A
    Ann Surg Oncol; 2013 Sep; 20(9):2822-7. PubMed ID: 23754547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires.
    Recondo G; Cosacow C; Cutuli HJ; Cermignani L; Straminsky S; Naveira M; Pitzzu M; De Ronato G; Nacuzzi G; Taetti G; Corsico S; Berrueta M; Colucci G; Gibbons L; Gutierrez L; García-Elorrio E
    Int J Qual Health Care; 2019 Nov; 31(9):682-690. PubMed ID: 31125084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.
    Yeboa DN; Xu X; Jones BA; Soulos P; Gross C; Yu JB
    Am J Clin Oncol; 2016 Dec; 39(6):568-574. PubMed ID: 24879475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
    Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of under-treatment of breast cancer in women 80 years of age and older.
    Van Leeuwen BL; Rosenkranz KM; Feng LL; Bedrosian I; Hartmann K; Hunt KK; Kuerer HM; Ross M; Singletary SE; Babiera GV;
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):315-20. PubMed ID: 20655242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
    Fisher B; Jeong JH; Dignam J; Anderson S; Mamounas E; Wickerham DL; Wolmark N
    J Natl Cancer Inst Monogr; 2001; (30):62-6. PubMed ID: 11773294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.